NTRK1 and cancer: Notably, Epidermal Growth Factor Receptor (EGFR), a receptor tyrosine kinase and an important target for cancer therapies, was found to have multiple glycosylation sites (N1044, N1094, N128, N352, N361, N413, N444, N528, N592, N603, N623) (Figure 3F).